PLIANT THERAPEUTICS, INC.
PLRX US7291391057
United States 19904
US-DE DOVER c/o COGENCY GLOBAL INC., 850 NEW BURTON ROAD SUITE 201
Registration Number 5762297
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 17 Insiders: 6
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Ouimette Mike |
10.99 USD |
10,230 Sold |
112,462 USD |
17/01/2025 | 22/01/2025 |
| Cheung Lily |
11.20 USD |
3,740 Sold |
41,892 USD |
17/01/2025 | 17/01/2025 |
| Lefebvre Eric |
11.20 USD |
18,478 Sold |
206,974 USD |
17/01/2025 | 17/01/2025 |
| Hull Hans CBO |
11.20 USD |
15,936 Sold |
178,501 USD |
17/01/2025 | 17/01/2025 |
| Cummings Keith Lamont CFO |
11.20 USD |
20,148 Sold |
225,680 USD |
17/01/2025 | 17/01/2025 |
| Coulie Bernard CEO |
11.20 USD |
52,419 Sold |
587,150 USD |
17/01/2025 | 17/01/2025 |
| Ouimette Mike |
11.20 USD |
13,270 Sold |
148,639 USD |
17/01/2025 | 17/01/2025 |
| Coulie Bernard |
11.56 USD |
38,710 Sold |
447,488 USD |
10/07/2024 | 10/07/2024 |
| Lefebvre Eric |
11.56 USD |
12,319 Sold |
142,408 USD |
10/07/2024 | 10/07/2024 |
| Hull Hans |
11.56 USD |
9,900 Sold |
114,444 USD |
10/07/2024 | 10/07/2024 |